RE: CENTAURUS COVID # face masks15 Jul 2022 08:42
Link copy not working
NTU’s patented research in nanoparticle coating and production, originally for cancer drug delivery, have been commercialised in ‘nano fertiliser’ plant and crop mineral biofortification products by new NTU spin-out Pharm2Farm Ltd. Pharm2Farm was acquired by Nonosynth PLC. through a £2.37 million share issue, a £5 million market raise, and has a current market valuation of £40 million. Pharm2Farm’s global sales of biofortification products, direct and via third parties, span the territories of Australia, South Korea, India, Canada, and USA, and have provided increases in turnover for suppliers and retailers and yield and income for farmers.
Castle